BIMI International Medical Reports Results For Quarter: Stock Soars 69%

BIMI International Medical, a leading healthcare products company, today announced its financial results for the quarter ended September 30. BIMI soars 69% in the pre-market trading today. It’s selling its single stock for $1.11. The company’s revenue for the three months ended on September 30, rose to $13,777,492 from $3,091,070 in the previous year. Gross profit for the period also increased to $2,29,109 from $1,271,278 in the previous year. For the third quarter of 2021, the company’s revenue grew by 12%, primarily due to the increase in sales of pharmaceuticals. During the same period, the operations of recently acquired hospitals contributed to the company’s growth. For the three-month period ended September 30, 2021, revenues were $13,777.49 million, and for the nine-month period ended September 30, 2021, revenues were $7,315,449.

adobestock 123504209The revenue of the pharmaceutical segment from the third quarter of 2017 to the third quarter of 2020 was $8,483,024. For the nine months ended September 30 of the same year, the revenue of the segment was $14,978,955. The revenue of the medical devices segment from 2020, to  September 30, 2021, was $669,276. For the nine months ended on the same period, the segment’s revenue was $2,524,017. The medical services segment’s revenue was $6,694,510 for the nine months ended September 2021.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.

Anthony Gonzales has 1700 posts and counting. See all posts by Anthony Gonzales